Speaker Profile

PhD, Full Professor, U. of Toronto

Biography
Dr. De Carvalho is a renowned expert in cancer epigenomics. He is a pioneer in the use of cancer epigenetics combined with advanced computational approaches for developing novel liquid biopsy tools applied to cancer early detection, classification and monitoring therapy response. Dr. De Carvalho have published over 80 high profile research papers, many of those featured in prestigious scientific journals such as Science, Nature Medicine, Cancer Cell among others and was an invited speaker to over 150 talks worldwide, including such prestigious venues as the Opening plenary lecture at AACR annual meeting. For his scientific contributions, Dr. De Carvalho received numerous awards including the Canadian Institutes of Health Research Early Career Award in Cancer. He received the Canada Research Chair in Cancer Epigenetics. Dr. De Carvalho founded and currently serves as CSO of Adela, a biotech company developing cell free DNA methylation liquid biopsy technology for cancer early detection, classification and monitoring therapy response.


 Session Abstract – PMWC 2024 Silicon Valley

Track 4 - January 25 9.00 A.M.-4.30 P.M.


Track Chair: Laura J. van 't Veer, UCSF

  • PMWC 2024 Award Ceremony
    Pioneer Honoree: David Sidransky, Johns Hopkins
    Pioneer Honoree: Helmy Eltoukhy
    Pioneer Honoree: AmirAli Talasaz, Guardant Health
  • Utilities of Liquid Biopsy in Biomarker Testing
    - Laura Vent Veer, UCSF
  • Status Quo of Clinical Liquid Biopsy (PANEL)
    Chair: Helmy Eltoukhy, Guardant Health
    - Sadakatsu Ikeda, Tokyo Medical University
    - Heather Parsons, Dana-Farber Cancer Institute
    - Sanjay Popat, The Royal Marsden
  • Liquid Biopsy for Health Monitoring and Disease Prevention (PANEL)
    Chair: Anne-Renee Hartman, Adela Bio
    - AmirAli Talasaz, Guardant Health
    - Heather Parsons, Dana-Farber Cancer Institute
    - Mary Pat Lancelotta, Adaptive Bio
    - Sylvia Katina Plevritis, Stanford
  • Multi-Cancer Early Detection Through Multi-Biomarker Class Liquid Biopsy Testing (PANEL)
    Chair: Tom Beer, Exact Sciences
    - Wendy Rubinstein, National Cancer Institute
    - Sheila D. Walcoff, Goldbug Strategies LLC
  • Keynote: Pioneering Liquid Nucleic Acids Tumor Fragments in Health and Diseases
    - David Sidransky, Johns Hopkins
  • New Approaches in Liquid Biopsy (PANEL)
    Chair: Victor Velculescu, Johns Hopkins
    - David Sidransky, Johns Hopkins
    - Dan Laudau, NY Genome Center
    - Daniel De Carvalho, University of Toronto
  • Global Implications: A scalable Liquid Biopsy for HPV-related Cervical Cancer (PANEL)
    Chair: Debra Fraser-Howze, D. Fraser Associates
    - Belinda Nedjai, Wolfson Institute of Population Health
    - Elisabeth Adams, Aquarius Population Health Limited
  • NCI Showcase
    - Xiaohui Ni, Early Dx
    - Daniel Kim, UCSC

×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by JUN. 6TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Contact Us:

Fields marked with an * are required 

Discount also depends on group size. The bigger group – the bigger discount.

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required